Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VITESS: GIA632 in Non-segmental Vitiligo
NCT07431177Phase 2Recruiting
- Sponsor
- Novartis
- Start
- Mar 2026
- Primary completion
- Jun 2028
- Countries
- 12
01
Overview
A Phase 2 trial of GIA632 in Vitiligo, sponsored by Novartis. Started Mar 2026; status: recruiting.
02
Drugs
GIA632
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT07431177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07431177.